February 7, 2014
The landscape of hepatitis C (HCV) management has undergone a near-fundamental transformation over the past couple of years. As new treatment options puff up like popcorn kernels on a hot stove and our understanding of the virus deepens, it's important to revisit what's changed -- and what further changes 2014 may hold in store.
Late in 2013, Andrea Cox, M.D., Ph.D., an associate professor of medicine at Johns Hopkins University School of Medicine, presented an update on HCV coinfection for an audience of HIV care providers. Read on for a summary of key points from her talk, including selected slides (which have been reposted with her permission).
Myles Helfand is the editorial director of TheBody.com and TheBodyPRO.com.
Follow Myles on Twitter: @MylesatTheBody.
|CROI 2015: The Future of Pre-Exposure Prophylaxis (Video)|
|CROI 2015: Addressing HIV and Cardiovascular Issues (Video)|
|CROI 2015: The Future of Antiretroviral Treatment for Prevention (Video)|
|A Timeline on Hepatitis C Virus Discovery|
|This Week in HIV Research: Subdermal Implant Provides Long-Acting Treatment; and Update on Indiana Outbreak|
|Ledipasvir and Sofosbuvir in HIV Coinfection|